SGMT Prakiraan wutah bathi kanggo taun ngarep sagimet.com

Lambang korporat lan logo Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences (SGMT) complies with environmental waste disposal regulations, while the dynamic chart on GURU.Markets displays the consensus estimate for net profit growth rates, where the latest parameter is -18.90. Business development relies on partnerships with medical centers to accelerate steatohepatitis therapy. High scalability is ensured by formula patents, guaranteeing global dominance with minimal production costs.

Sagimet (SGMT): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 21.02.2024 nganti 18.11.2026

SGMT (Sagimet Biosciences, Inc.): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:SGMT, sagimet.com
Produk dadi Sagimet Biosciences Inc.

The projected profit growth for the coming year allows for an assessment of the business's future value, neutralizing the time lag associated with standard reporting. This metric measures the expected EPS dynamics, accounting for current inflationary risks and operating expenses. By analyzing the consensus estimate of net profit growth rates, an investor can discern the company's market development vector. However, for Sagimet Biosciences (SGMT), geopolitical instability and logistical disruptions could significantly adjust these expectations.

Analisis perusahaan pesaing

ASND (Ascendis) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Pharmaceuticals|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (Rhythm Pharma)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep akerotx.com AKRO|Metsera Therapeutics (MTSR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MLTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CRNX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi kanggo taun ngarep|SLNO - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Amicus Corp|89bio Pharma (ETNB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep agios.com (AGIO)|Prakiraan wutah bathi saben saham kanggo taun ngarep structuretx.com GPCR|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MiMedx Group Inc MDXG|Dinamika bathi saben saham sing diarepake ing taun ngarep RZLT|lexpharma.com - Prakiraan wutah bathi kanggo taun ngarep|MBX (MBX Biosciences Inc) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|ALT: Prakiraan wutah bathi kanggo taun ngarep|Aardvark Therapeutics Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|BIOA (bioagelabs.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Biomea Fusion (BMEA)|Prakiraan wutah bathi kanggo taun ngarep QNCX|Proyeksi tambahing bathi saben saham ing taun ngarep GUTS|Prakiraan wutah bathi kanggo taun ngarep VTVT (vTv Therapeutics Inc.)|Dinamika bathi saben saham sing diarepake ing taun ngarep ATPC|Pluristem Therapeutics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep synlogictx.com SYBX|LPCN: Prakiraan wutah bathi kanggo taun ngarep|Matinas BioPharma Holdings, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|SPRB (Spruce Biosciences Inc.) - Prakiraan wutah bathi kanggo taun ngarep|galecto.com (GLTO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep organovo.com ONVO|Radius Health (RDUS) - Prakiraan wutah bathi resik saben saham ing taun ngarep